2006 Cultivation History Safety 
Canna Law Blog
OCTOBER 1, 2020
This post examines the history of religious exemptions to the CSA. According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. In 2006, the U.S.
Cannabis Law Report
JULY 20, 2021
Salama was Assistant Branch Chief of the California Department of Public Health’s Manufactured Cannabis Safety Branch. Eidson was the Assistant Director of the California Department of Food and Agriculture’s CalCannabis Cultivation Licensing Division. Chief Deputy Director – Rasha Salama. Administration Division – Melissa Eidson.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JANUARY 23, 2020
the promotion of cultivation and the agro-industrial chain. the European Food Safety Authority and establishes procedures in the. food safety; Having regard to Regulation (EC) no. 1881/2006 of the Commission dated 19. December 2006 which defines the maximum levels of some contaminants. 20A00016). (OJ 178/2002 no.
Cannabis Law Report
JUNE 2, 2022
Answers to these questions are applicable to: Site inspectors, whose chance of encountering unintentional contact with cannabis has risen as both possession and cultivation (by individuals and commercial operations) has become permissible. THC metabolism (adapted from Musshoff and Madea, 2006). State legalization of cannabis (i.e.,
Cannabis Law Report
OCTOBER 14, 2021
In 2006 Tiffiny earned her J.D. in history. DCC regulations were established to ensure product safety and public protection. As the cannabis industry continues to expand and legalization on the federal level is imminent, regulations are likely to become even more restrictive in the interest of public safety.
Cannabis Law Report
APRIL 8, 2022
To celebrate this, we invite you to take a trip down memory lane and review highlights from every year of our history. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. Rick Doblin, Ph.D., and Michael Mithoefer, M.D.,
Cannabis Law Report
NOVEMBER 24, 2021
However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It also has an extensive and diverse history of medicinal use. 2018 ; Frankhauser 2008 ).
Expert insights. Personalized for you.
98 
Let's personalize your content